The increasing awareness and diagnosis rates are expected to drive the growth of the Charcot Marie Tooth disease market over the forecast period. According to the National Institute of Neurological Disorders and Stroke, Charcot-Marie-Tooth disease affects approximately 1 in 2,500 people in the United States. However, most medical professionals are still unaware of this disease. Raising awareness about the condition and its signs and symptoms is important for early diagnosis and treatment. Non-profit organizations like CMTA (Charcot-Marie-Tooth Association) educate patients and physicians through publications, conferences, patient forums and seminars. Early detection can help slow disease progression.

The other driver is the robust pipeline of drugs under research and development. There is no cure for CMT yet but many companies are exploring gene therapy, neurotrophic factors and other innovative treatment approaches that can potentially stop or reverse nerve damage. Some drugs in late-stage clinical trials show promise. This robust pipeline is expected to lead to major treatment breakthroughs in the coming years, boosting market growth.

The global Charcot Marie Tooth Disease Market is expected to witness high growth, exhibiting CAGR of 23.% over the forecast period, due to increasing prevalence of CMT disease globally. As per recent study, CMT affects nearly 1 in 2,500 people worldwide.

North America region currently dominates the Charcot Marie Tooth Disease Market owing to increasing R&D investments, supportive government initiatives and presence of key players in the region. Europe is the second largest market due to rising cases of CMT disease. Asia Pacific region is expected to witness fastest growth during forecast period due to increasing healthcare expenditure and growing awareness.

Key players operating in the Charcot Marie Tooth Disease Market are Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp, Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc. These major players are adopting various inorganic strategies such as collaborations and partnerships to gain higher market share.

Read More

https://www.dailyprbulletin.com/charcot-marie-tooth-disease-market-size-share-growth-outlook-2023/